Salbutamol-ratiopharm N Dosieraerosol

Salbutamol-ratiopharm N Dosieraerosol is a widely used bronchodilator medication prescribed for the treatment of asthma and chronic obstructive pulmonary disease (COPD). It is a generic formulation of salbutamol, delivered via a pressurized metered-dose inhaler (pMDI).

The ratiopharm brand was founded in Ulm, Germany, in 1974 by Adolf Merckle and became one of the first and most successful generic pharmaceutical companies in the country. Since 2010, the brand has been part of Teva Pharmaceutical Industries, a global leader in the generics market. While the brand has deep German roots and maintains major manufacturing facilities in Ulm, the actual production of specific components like the canister and active ingredients may occur across Teva's global supply chain network.